Royston Aaron 4/A
4/A · Ventyx Biosciences, Inc. · Filed Apr 26, 2023
Insider Transaction Report
Form 4/AAmended
Royston Aaron
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2022-06-09+21,825→ 21,825 totalExercise: $16.54Exp: 2032-06-09→ Common Stock (21,825 underlying)
Footnotes (2)
- [F1]The Form 4 filed on June 10, 2022, erroneously reported that the reporting person received an option award for 13,301 shares on June 9, 2022. The correct option award amount is for 21,825 shares.
- [F2]The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or, (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date the option was granted, in each case, subject to the reporting person continuing to be Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date.